SELCO Foundation under the Zayed Sustainability Prize's Beyond2020 initiative the UAE’s pioneering award for innovative ...

The Indian Council of Medical Research (ICMR), under its Medical Innovations Patent Mitra initiative, facilitated the licensing of three indigenous biomedical technologies to leading Indian ...

OptraSCAN, Inc., a California-headquartered digital pathology and image analysis company in which Molbio Diagnostics Limited acquired a majority stake in 2025, announced that it has received US Food ...

Glenmark Pharma gets US FDA approval to expand Ryaltris use for children aged 6-12: Our Bureau, Mumbai Tuesday, July 21, 2026, 15:10 Hrs [IST] Glenmark Specialty S.A. announced th ...

Lupin spins out two oncology programmes to Kaveri Therapeutics: Our Bureau, Mumbai Tuesday, July 21, 2026, 15:20 Hrs [IST] Global pharma major Lupin Limited announced the strategi ...

NIHR announces first studies funded under initiative to decarbonise health and social care: United Kingdom Tuesday, July 21, 2026, 15:00 Hrs [IST] The NIHR has announced the first ...

Consano Bio receives US FDA IND clearance to expand the C-1101 chronic sciatica clinical development programme into US: Burlington, Massachusetts Tuesday, July 21, 2026, 14:00 Hrs ...

The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 159 drug samples tested across the country during the month of June, 2026, as Not of Standard Quality (NSQ). Out of the ...

Jal Jeevan Mission powers India's fight against diarrhoeal diseases: Our Bureau, Bengaluru Tuesday, July 21, 2026, 14:40 Hrs [IST] Seven key Ministries and Departments of the Gove ...

Galderma introduces Alastin in Japan and key markets across Asia Pacific: Zug, Switzerland Tuesday, July 21, 2026, 13:00 Hrs [IST] Galderma, the pure-play dermatology category lea ...

DNA Script inks distribution agreement with Imperial Life Sciences, expands access to on-demand DNA synthesis in India: Our Bureau, Mumbai Tuesday, July 21, 2026, 12:00 Hrs [IST] ...

Armata Pharma achieves key progress across clinical, regulatory and manufacturing activities supporting planned phase 3 initiation of AP-SA02: Los Angeles Tuesday, July 21, 2026, ...